BioSpace News Archive

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced positive top-line data from its clinical trial with Bentrio™ nasal spray in house dust mite allergic rhinitis.

Protect Pharmaceutical Corporation, Inc. “OTC:(PRTT)” announces that after many months of strategic planning and development, the two companies are ready to announce the details of their upcoming merger.

Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of 22,665,000 shares of its common stock.

TFF Pharmaceuticals, Inc. announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022.

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that it received Triangle Business Journal’s 2022 Company of the Year award, one of two such awards presented at the 2022 Life Sciences Award ceremony.

AcelRx Pharmaceuticals, Inc. today announced that Chief Executive Officer, Vince Angotti will present in-person and be available for one-on-one meetings throughout the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Miami, FL.

Biomarker is a general term which refers to any quantifiable or measurable biological parameter.

Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds).

Vera Therapeutics, Inc. (Nasdaq: VERA), today announced new clinical data for its lead product candidate, atacicept, from the Phase 2a JANUS trial in patients with IgA nephropathy (IgAN) and first-time results from a post-hoc analysis of the Phase 2 APRIL-SLE study in patients with systemic lupus erythematosus (SLE).

Regulatory News: Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 20, 2022, in Marseille.